Barclays PLC Absci Corp Transaction History
Barclays PLC
- $377 Billion
- Q3 2024
A detailed history of Barclays PLC transactions in Absci Corp stock. As of the latest transaction made, Barclays PLC holds 131,504 shares of ABSI stock, worth $393,196. This represents 0.0% of its overall portfolio holdings.
Number of Shares
131,504
Previous 131,504
-0.0%
Holding current value
$393,196
Previous $503,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ABSI
# of Institutions
128Shares Held
59.3MCall Options Held
255KPut Options Held
93.6K-
Redmile Group, LLC San Francisco, CA8.25MShares$24.7 Million2.06% of portfolio
-
Fred Alger Management, LLC New York, NY7.57MShares$22.6 Million0.15% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.34MShares$18.9 Million0.23% of portfolio
-
Black Rock Inc. New York, NY5.34MShares$16 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.94MShares$14.8 Million0.0% of portfolio
About Absci Corp
- Ticker ABSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 92,843,504
- Market Cap $278M
- Description
- Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....